Navigation Links
Pharmacyclics Reports First Quarter Fiscal 2009 Financial Results
Date:10/30/2008

gh quality people. Most of them are deeply experienced with our lead molecule motexafin gadolinium. In acquiring three promising compounds from Celera, we were very fortunate to inherit a group of experienced scientists that have been closely associated with each of these products from their onset. Our scientists are making great strides in forwarding a product pipeline that is novel, differentiated and full of potential. Without question, these are challenging times and historically those that rise up to face the challenges before them and put solutions into action gain strength in the process and become a good deal more viable than ever before. This is our intention. At Pharmacyclics we are dedicated to advancing our small molecule cancer drug candidates through clinical trials and establishing ourselves as a viable pharmaceutical company bringing real solutions to unmet or underserved patients' needs.

"Our executive team looks forward to providing shareholders, current and prospective, with a full update concerning our progress and plans for the future at our annual meeting scheduled for December 12, 2008."

About Pharmacyclics

Pharmacyclics is a pharmaceutical company developing innovative products to treat cancer and other serious diseases. The company is leveraging its small-molecule drug development expertise to build a pipeline in oncology and immune diseases based on a wide range of targets, pathways and mechanisms. More information about the company, its technology, and products can be found at http://www.pharmacyclics.com. Pharmacyclics(R) and the "pentadentate" logo(R) are registered trademarks of Pharmacyclics, Inc.

NOTE: Other than statements of historical fact, the statements made in this press release about future plans and timelines for our preclinical studies and clinical trials, progress of and reports of results from preclinical studies and clinical trials, clinic
'/>"/>

SOURCE Pharmacyclics, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Pharmacyclics Reports Fourth Quarter and Fiscal 2008 Financial Results
2. Pharmacyclics Announces It Received Nasdaq Notice of Compliance
3. Pharmacyclics Announces It Received Nasdaq Notification
4. Pharmacyclics Announces Multiple Presentations at the American Association for Cancer Research Annual Meeting
5. Mylan Reports Adjusted Diluted EPS of $0.23 for the Quarter Ended Sept. 30, 2008
6. Vanda Pharmaceuticals Reports Third Quarter 2008 Results
7. United Therapeutics Reports Third Quarter 2008 Financial Results
8. BioMed Realty Trust Reports Third Quarter 2008 Financial Results
9. Varian, Inc. Reports Strong Fourth Quarter 2008 Results
10. Sangamo BioSciences Reports Third Quarter 2008 Financial Results
11. VNUS Medical Technologies Reports Third-Quarter 2008 Results: 25% Growth in Net Product Revenues and 29% Growth in Unit Sales Over Third Quarter 2007
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/21/2013)... , May 21, 2013  On May ... FCN ), the global business advisory firm dedicated ... value (the "Company"), announced that it has combined ... were formerly included within the Corporate Finance/Restructuring segment ... segment to form a single integrated practice whose ...
(Date:5/21/2013)... of a new study led by George Washington ... that nucleation of ice in small droplets is ... behavior at the nanoscale. The formation of ice ... research question whose answer also has important implications ... The crystallization of ice from supercooled water is ...
(Date:5/21/2013)... Clinverse, Inc. , a global ... announced today it has formed a strategic alliance ... FLS eClinical commerce platform aggregates data collected through ... ™, Aggregate Spend Solutions’ recently-launched flagship product, is ... transfer of value at investigator meetings or any ...
(Date:5/21/2013)... Many have long discussed the link between ... physicians from Clinical Psychiatry.com readdressed the topic ... and suggested using hypnotherapy and other mental ... stress that cause acne. , Doctors in the article ... about, stress causes changes in the skin that have ...
Breaking Biology Technology:FTI Consulting Releases Realigned Segment Information Reflecting Newly Combined Health Solutions Practice 2Study led by GW professor provides better understanding of water's freezing behavior at nanoscale 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 2Clinverse, Inc. Announces Strategic Alliance with Aggregate Spend Solutions, LLC 3Adult Acne Treatment, Probiotic Action Explains How Hypnotherapy and Probiotics May Cure Various Skin Conditions 2
... Novel Proteasome Inhibitor in ... Myeloma, SOUTH SAN FRANCISCO, Calif. and NORWALK, Conn., ... Proteolix, Inc. today,announced the enrollment of the first patient ... potent and selective proteasome,inhibitor, carfilzomib (PR-171), in patients with ...
... BioVex Inc, a biotechnology,company developing clinical stage treatments ... today that it has appointed Dr. Thaddeus,Pullano, 53, ... http://www.newscom.com/cgi-bin/prnh/20070815/NYW022 ) Previously, Dr. Pullano ... Acambis from 2003 to 2007. In this role, ...
... Science Addressing Increased Demand for Food, Feed, Fuel, ... DuPont (NYSE: DD ),Chairman and CEO Charles ... Officer Thomas M. Connelly, and Group Vice President ... updated investors on DuPont,businesses serving the agriculture and ...
Cached Biology Technology:The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 2The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 3The Multiple Myeloma Research Consortium (MMRC) and Proteolix Initiate Phase 2 Clinical Trial Investigating Carfilzomib for the Treatment of Multiple Myeloma 4BioVex Appoints Dr. Thaddeus Pullano as VP, Quality Assurance 2DuPont Leaders Brief Investors on Agriculture Businesses 2DuPont Leaders Brief Investors on Agriculture Businesses 3
(Date:5/22/2013)... Calif., May 22, 2013 Early screening for prostate ... pregnancy testing is for women, thanks to UC Irvine ... American Chemical Society . , After more than a ... way to clearly identify clinically usable markers for prostate ... detected far sooner, with greater accuracy and at dramatically ...
(Date:5/22/2013)... YORK, May 22, 2013. Plastic additives known as ... about everywhere: They turn up in flooring, plastic ... to the Centers for Disease Control and Preventionthe ... phthalates have come under increasing scrutiny. A growing ... (which can leech from packaging and mix with ...
(Date:5/21/2013)... device attached to a whale entangled in fishing gear, ... changed a whale,s diving and swimming behavior. The monitoring ... and migrate, depletes their energy as they drag gear ... slow death. , The scientists in this entanglement response ... two-year-old female North Atlantic right whale called Eg 3911. ...
Breaking Biology News(10 mins):UCI chemists devise inexpensive, accurate way to detect prostate cancer 2UCI chemists devise inexpensive, accurate way to detect prostate cancer 3Study links chemicals widely found in plastics and processed food to elevated blood pressure in children and teens 2Study reveals how fishing gear can cause slow death of whales 2Study reveals how fishing gear can cause slow death of whales 3
... went looking for fossil whales and dinosaurs in Saudi Arabia, ... primate fossil. But the skull he stumbled upon ... apes and monkeys may have looked like and when the ... at the University of Michigan and the Saudi Geological Survey ...
... Rice University scientists have found the "ultimate" solvent for ... brings the creation of a highly conductive quantum nanowire ... of bundling, making them less useful than when they,re ... Pasquali, a professor in chemical and biomolecular engineering and ...
... at the U.S. Department of Energy,s Savannah River ... and Mississippi State University to decrease mold growth ... Funded by the Department of Homeland ... (SERRI), Mississippi State University asked SRNL and Tuskegee ...
Cached Biology News:Fossil find puts a face on early primates 2Fossil find puts a face on early primates 3Fossil find puts a face on early primates 4Nanotubes pass acid test 2Nanotubes pass acid test 3SRNL works to decrease hazards from mold in water damaged homes 2